4/A//SEC Filing
RAPPAPORT ANDREW 4/A
Accession 0001415889-22-006959
CIK 0001750284other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 5:06 PM ET
Size
5.9 KB
Accession
0001415889-22-006959
Insider Transaction Report
Form 4/AAmended
RAPPAPORT ANDREW
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-17+21,520→ 21,520 totalExercise: $3.61Exp: 2032-06-16→ Common Stock (21,520 underlying)
Footnotes (2)
- [F1]This amendment is being filed solely for the purpose of correcting the transaction date and exercise price. The correct transaction date is "June 17, 2022" and the correct exercise price is "$3.61" as shown herein.
- [F2]The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 17, 2022, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001162157
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 5:06 PM ET
- Size
- 5.9 KB